Search International and National Patent Collections

1. (WO2018184185) OZANIMOD ADDITION SALT CRYSTAL, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION, AND USES

Pub. No.:    WO/2018/184185    International Application No.:    PCT/CN2017/079654
Publication Date: Fri Oct 12 01:59:59 CEST 2018 International Filing Date: Sat Apr 08 01:59:59 CEST 2017
IPC: C07D 271/06
A61K 31/4245
A61P 37/00
Applicants: SOLIPHARMA LLC
杭州领业医药科技有限公司
Inventors: SHENG, Xiaohong
盛晓红
SHENG, Xiaoxia
盛晓霞
ZHENG, Jianfeng
郑剑锋
Title: OZANIMOD ADDITION SALT CRYSTAL, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION, AND USES
Abstract:
Disclosed is an ozanimod addition salt crystal, which is provided with one or more improved characteristics compared with a known ozanimod solid form. Also disclosed are a preparation method for the ozanimod addition salt crystal, a pharmaceutical composition of same, and uses thereof in preparing a medicament for diseases or disorders medically requiring optional regulation, activation, excitement, inhibition or antagonism of sphingosine-1-phosphate receptor.